SANTA ANA, Calif.--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) today announced that the company purchased approximately $124 million aggregate principal amount of its 3.25% convertible senior subordinated notes due 2026 for approximately $51.8 million and approximately $57 million aggregate principal amount of its 2.50% convertible senior subordinated notes due 2024 for approximately $45.3 million. These repurchases were consummated pursuant to privately negotiated transactions with holders of the notes that had previously contacted the company. The company funded these repurchases by drawing approximately $97 million on its senior revolving credit facility.
